https://orcid.org/0000-0002-3226-7231
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Cody Palmer, Christiaan Dolk, Ugne Sabale, Wei Wang & Kunal Saxena. (2024) Cost-effectiveness of nonavalent HPV vaccination in the Netherlands. Expert Review of Vaccines 23:1, pages 312-323.
Read now
Read now
Ibrahim Diakite, Sylvi Nguyen, Ugne Sabale, Andrew Pavelyev, Kunal Saxena, Athar Ali Tajik, Wei Wang & Cody Palmer. (2023) Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases. Journal of Medical Economics 26:1, pages 1085-1098.
Read now
Read now
Ibrahim Diakite, Jeffrey Kyle, Sujian Situ, Peng Bai, Xingxing Zhang, Wei Wang & Vincent Daniels. (2023) Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A simulation study. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Articles from other publishers (18)
C. Shannon Pfingstag. (2023) Increasing Rates of Human Papillomavirus Catch‐Up Vaccination at a Sexual/Reproductive Health Clinic: A Quality Improvement Project. Journal of Midwifery & Women's Health.
Crossref
Crossref
Anna-Lise Williamson. (2023) Recent Developments in Human Papillomavirus (HPV) Vaccinology. Viruses 15:7, pages 1440.
Crossref
Crossref
Mariana Arevalo, Naomi C. Brownstein, Junmin Whiting, Susan T. Vadaparampil, Katharine J. Head, Cathy D. Meade, Jessica Y. Islam, Monica L. Kasting, Clement K. Gwede, Veronica Barrios‐Monroy & Shannon M. Christy. (2023) Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18–26 and 27–45 years in the United States: A cross‐sectional study. Cancer 129:8, pages 1237-1252.
Crossref
Crossref
Levy Jäger, Oliver Senn, Thomas Rosemann & Andreas Plate. (2023) Assessment of Human Papillomavirus Vaccination in Primary Care Among Swiss University Students. JAMA Network Open 6:3, pages e233949.
Crossref
Crossref
Aasith Villavicencio, Gray Kelsey, Nicholas F. Nogueira, Julia Zukerberg, Ana S. Salazar, Lucila Hernandez, Patricia Raccamarich & Maria Luisa Alcaide. (2023) Knowledge, attitudes, and practices towards HPV vaccination among reproductive age women in a HIV hotspot in the US. PLOS ONE 18:1, pages e0275141.
Crossref
Crossref
Laura M King, Joseph A Lewnard & Linda M Niccolai. (2023) Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review. Open Forum Infectious Diseases 10:1.
Crossref
Crossref
Samruddhi H Charde & Rupesh A Warbhe. (2022) Human Papillomavirus Prevention by Vaccination: A Review Article. Cureus.
Crossref
Crossref
Asami Yagi, Yutaka Ueda, Satoshi Nakagawa, Sayaka Ikeda, Mamoru Kakuda, Kosuke Hiramatsu, Ai Miyoshi, Eiji Kobayashi, Toshihiro Kimura, Taichi Mizushima, Yukio Suzuki, Masayuki Sekine, Kei Hirai, Tomio Nakayama, Etsuko Miyagi, Takayuki Enomoto & Tadashi Kimura. (2022) Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?. Vaccines 10:9, pages 1455.
Crossref
Crossref
Kwame Owusu-EduseiCody PalmerOlga Ovcinnikova, Giampiero Favato & Vincent Daniels. (2022) Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom. Journal of Health Economics and Outcomes Research 9:1, pages 140-150.
Crossref
Crossref
Kwame Owusu-Edusei, Cody Palmer, Olga Ovcinnikova, Giampiero Favato & Vincent Daniels. (2022) Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom. Journal of Health Economics and Outcomes Research 9:1.
Crossref
Crossref
Shasha Gao, Maia Martcheva, Hongyu Miao & Libin Rong. (2022) The impact of vaccination on human papillomavirus infection with disassortative geographical mixing: a two-patch modeling study. Journal of Mathematical Biology 84:6.
Crossref
Crossref
Haluk Damgacioglu, Kalyani Sonawane, Jagpreet Chhatwal, David R. Lairson, Gary M. Clifford, Anna R. Giuliano & Ashish A. Deshmukh. (2022) Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: A modeling study. The Lancet Regional Health - Americas 8, pages 100143.
Crossref
Crossref
Amita Kulkarni, Ling Chen, Alexander Melamed, Dawn L. Hershman & Jason D. Wright. (2022) Trends in human papillomavirus vaccination among women aged 27 to 45 years, from 2017 to 2019. American Journal of Obstetrics and Gynecology 226:4, pages 568-570.e1.
Crossref
Crossref
Soneet Dhillon & Eden Lake. (2022) Skin Cancer Back to Basics. Journal of the Dermatology Nurses' Association 14:2, pages 76-81.
Crossref
Crossref
Vincent Daniels, Kunal Saxena, Oscar Patterson-Lomba, Andres Gomez-Lievano, Alfred Saah, Alain Luxembourg, Christine Velicer, Ya-Ting Chen & Elamin Elbasha. (2022) Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom. Vaccine 40:14, pages 2173-2183.
Crossref
Crossref
Colm Mac Eochagain, Robert Power, Imelda Parker & Donal Brennan. (2022) HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis. Journal of Gynecologic Oncology 33:3.
Crossref
Crossref
Li Dong, Mari Nygård & Bo T. Hansen. (2021) Sociodemographic Correlates of Human Papillomavirus Vaccine Uptake: Opportunistic and Catch-Up Vaccination in Norway. Cancers 13:14, pages 3483.
Crossref
Crossref
Vincent Daniels, Kunal Saxena, Craig Roberts, Smita Kothari, Shelby Corman, Lixia Yao & Linda Niccolai. (2021) Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis. Vaccine 39:20, pages 2731-2735.
Crossref
Crossref